Predicting factors for central or lateral lymph node metastasis in conventional papillary thyroid microcarcinoma - 20/06/20

Abstract |
Background |
Optimal management for papillary thyroid microcarcinoma (PTMC) remains controversial. The purpose of this study was to explore risk factors predictive of cervical lymph node metastasis in conventional PTMCs.
Methods |
Conventional PTMC patients (n = 2,404) undergoing surgery between 2010 and 2017 were grouped and analyzed according to the positivity of cervical lymph node.
Results |
Central lymph node (CLN) metastases and lateral lymph node (LLN) metastases were observed in 915 (38.1%) and 184 (7.7%) cases, respectively. Multivariate analysis found that male (odds ratio [OR] = 1.974, p < 0.001), younger age (OR = 1.601, p < 0.001), tumor size (OR = 1.935, p < 0.001), extrathyroidal extension (ETE) (OR = 1.647, p < 0.001), multifocality (OR = 1.416, p < 0.001), and intrathyroidal spreading (OR = 3.355, p < 0.001) predicted increased CLN metastasis. In particular, younger age, multifocality, and intrathyroidal spreading were significantly associated with a high number of CLN metastases (n ≥ 5). The presence of CLN metastasis was strongly associated with LLN metastasis (OR = 5.426, p < 0.001).
Conclusion |
Male, younger age, tumor size, ETE, multifocality, and intrathyroidal spreading predict increased CLN metastasis in PTMCs. In patients with suspicious lateral lymphadenopathy, the presence of CLN metastasis is independently associated with LLN metastasis.
Le texte complet de cet article est disponible en PDF.Highlights |
• | Male, younger age, and tumor size are predictive of CLN metastasis in PTMCs. |
• | ETE, multifocality, and intrathyroidal spreading are associated with CLN metastasis. |
• | Coexisting chronic lymphocytic thyroiditis is associated with less CLN metastasis. |
• | The presence of CLN metastasis is independently associated with LLN metastasis. |
• | BRAF V600E mutation is not associated with cervical lymph node metastasis. |
Keywords : Papillary thyroid microcarcinoma, Lymph node metastasis, Risk factors
Plan
Vol 220 - N° 2
P. 334-340 - août 2020 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
